[Ulcers in a patient with chronic lymphocytic leukemia].
León-Mateos
A
A
Departamento de Dermatología, POVISA, Vigo, España. alm1313@gmail.com
Sánchez-Aguilar
D
D
Toribio
J
J
D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use; D004427:Ear Diseases / Q000209:etiology* / Q000821:virology; D004431:Ear, External / Q000821:virology; D006229:Hand Dermatoses / Q000209:etiology* / Q000821:virology; D006561:Herpes Simplex / Q000175:diagnosis* / Q000209:etiology / Q000821:virology; D006801:Humans; D016867:Immunocompromised Host; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced / Q000150:complications; D012883:Skin Ulcer / Q000209:etiology* / Q000821:virology; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use
D000964:Antimetabolites, Antineoplastic; D014740:Vidarabine; C024352:fludarabine